The board of directors of Charmacy Pharmaceutical Co., Ltd. announced that Mr. Lin Zhixiong ("Mr. Lin") has submitted his resignation letter to the Company to resign as chief financial officer of the Company, with effect from 8 April 2022, for personal reasons. Mr. Lin has confirmed that there is no disagreement between him and the Board, and that there is no matter relating to his resignation that shall be brought to the attention of the shareholders of the Company or the Stock Exchange.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 HKD | -1.14% | -39.58% | -32.87% |
May. 21 | Charmacy Pharmaceutical to Pay Final Dividend | MT |
Apr. 01 | Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.87% | 120M | |
-38.61% | 13.83B | |
-31.33% | 10.96B | |
+13.51% | 6.34B | |
-8.33% | 6.08B | |
-30.66% | 6.05B | |
+72.00% | 5.04B | |
-1.61% | 4.67B | |
-4.84% | 4B | |
-16.14% | 3.28B |
- Stock Market
- Equities
- 2289 Stock
- News Charmacy Pharmaceutical Co., Ltd.
- Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Lin Zhixiong as Chief Financial Officer